06.11.2013
- Swiss pharmaceutical giant Roche has received the green light from the U.S. Food and Drug Adminstration (FDA) to sell Gazyva (obinutuzumab), its new agent to treat chronic...
22.07.2013
- Swiss drugmaker Roche faces the prospect of hiring an outsider to replace its chairman of 16 years after its most suitable board members turned down the job. The 117-year old...
15.07.2013
- Buying Alexion Pharmaceuticals would help Roche make a splash in the newly lucrative area of rare or so-called orphan diseases, but it could command a price that the Swiss...
10.07.2013
- GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways antibody...
07.05.2013
- Just two years ago, Regeneron Pharmaceuticals was a relatively obscure biotech company in the village of Tarrytown, a picturesque New York suburb better known for "Rip Van Winkle,"...
05.03.2013
- Roche's influential Chairman Franz Humer said on Tuesday he will not stand for re-election next year when he will have served 16 years at the helm, potentially accelerating a shift...
18.01.2013
- Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should...
15.01.2013
- Swiss drugmaker Roche has hired a leading American academic in a bid to revive part of its research operations which have struggled to shake off a string of high-profile and costly...
